Paul S. Meltzer

Rutgers, The State University of New Jersey

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index121

i10-index347

Publications734

Citations61,767

Grants

50 total · 0 active

NIH #1ZIABC011328-16

Characterization of the Osteosarcoma Genome

Amount: $1.8M
Period: — → —
PIs: 1
Est. capacity / PI: ~30 students

Awarded at DIVISION OF BASIC SCIENCES - NCI

NIH #1ZIABC011091-18

Cancer Genomics Technology Development

Amount: $726K
Period: — → —
PIs: 1
Est. capacity / PI: ~12 students

Awarded at DIVISION OF BASIC SCIENCES - NCI

NIH #1ZIABC010759-20

Functional Genomics of Sarcoma

Amount: $1.1M
Period: — → —
PIs: 1
Est. capacity / PI: ~18 students

Awarded at DIVISION OF BASIC SCIENCES - NCI

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 18 of 18

Characterizing Paratesticular Neoplasms in Proteus Syndrome
The American Journal of Surgical Pathology · 2025-12-10
Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
2025-11-25
Supplementary Appendix S1 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
2025-11-25
Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line data
STAR Protocols · 2025-09-25 · 2 citations
A Flexible Procedure for Performing Telomere FISH and Immunofluorescence in Cells Expressing Fluorescent Proteins
Journal of Visualized Experiments · 2025-09-05
Azanucleoside treatment leads to B-cell precursor acute lymphoblastic leukemia
Blood Neoplasia · 2025-08-20
Disruption of normal stem cell function and transmission of myelodysplastic syndrome by self-renewal of committed myeloid lineage cells
Stem Cell Reports · 2025-07-03
194 | A NOVEL APPROACH FOR CLASSIFICATION OF SPLENIC B CELL LYMPHOMA USING DNA METHYLATION REVEALS DIVERSE BIOLOGICAL DISEASE MECHANISMS
Hematological Oncology · 2025-06-01
Abstract 3890: Novel miFISH single-cell approach gives new insights into chromosomal instability and evolution of colorectal cancers
Cancer Research · 2025-04-21
Cancer-associated DAXX mutations reveal a critical role for ATRX localization in ALT suppressionPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2024-11-20 · 1 citations
Cytarabine Resistance Leads to a Specific Mutator Phenotype in Leukemic Cells
Blood · 2024-11-05
Supp_Fig_S1-S19 from The DNA Methyltransferase Inhibitor 5-Aza-4′-thio-2′-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia DevelopmentPreprint
2024-08-01
Data from The DNA Methyltransferase Inhibitor 5-Aza-4′-thio-2′-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia DevelopmentPreprint
2024-08-01
Supp_Tables_S1-S13 from The DNA Methyltransferase Inhibitor 5-Aza-4′-thio-2′-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia DevelopmentPreprint
2024-08-01
Supp_Fig_S1-S19 from The DNA Methyltransferase Inhibitor 5-Aza-4′-thio-2′-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia DevelopmentPreprint
2024-08-01
Data from The DNA Methyltransferase Inhibitor 5-Aza-4′-thio-2′-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia DevelopmentPreprint
2024-08-01
Supp_Tables_S1-S13 from The DNA Methyltransferase Inhibitor 5-Aza-4′-thio-2′-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia DevelopmentPreprint
2024-08-01
Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β
Oncogene · 2024-07-17

Open author page on OpenAlex →